Similar articles

• Mansonella perstans--the importance of an endosymbiont.

  Hoerauf A. Hoerauf A. N Engl J Med. 2009 Oct 8;361(15):1502-4. doi: 10.1056/NEJMe0905193. N Engl J Med. 2009. PMID: 19812409 No abstract available.
• A randomized trial of doxycycline for Mansonella perstans infection.

  Coulibaly YI, Dembele B, Diallo AA, Lipner EM, Doumbia SS, Coulibaly SY, Konate S, Diallo DA, Yalcouye D, Kubofcik J, Doumbo OK, Traore AK, Keita AD, Fay MP, Traore SF, Nutman TB, Klion AD. Coulibaly YI, et al. N Engl J Med. 2009 Oct 8;361(15):1448-58. doi: 10.1056/NEJMoa0900863. N Engl J Med. 2009. PMID: 19812401 Free PMC article. Clinical Trial.
• Anti-Wolbachia treatment for lymphatic filariasis.

  Stolk WA, de Vlas SJ, Habbema JD. Stolk WA, et al. Lancet. 2005 Jun 18-24;365(9477):2067-8. doi: 10.1016/S0140-6736(05)66714-1. Lancet. 2005. PMID: 15964428 No abstract available.
• Experimental infection of humans with filariae.

  Nutman TB. Nutman TB. Rev Infect Dis. 1991 Sep-Oct;13(5):1018-22. doi: 10.1093/clinids/13.5.1018. Rev Infect Dis. 1991. PMID: 1962076 Review.
• Antibiotics for the treatment of onchocerciasis and other filarial infections.

  Hoerauf A, Adjei O, Büttner DW. Hoerauf A, et al. Curr Opin Investig Drugs. 2002 Apr;3(4):533-7. Curr Opin Investig Drugs. 2002. PMID: 12090719 Review.